RT Journal Article
SR Electronic
T1 Cost-Benefit Analysis for Universal Cataract Coverage in India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.24.23296031
DO 10.1101/2023.09.24.23296031
A1 Arora, Anoushka
A1 Vuddemarry, Madhurima
A1 Reddy, Chaitanya
A1 Iyer, Himanshu
A1 Nimkar, Pushkar
A1 Zadey, Siddhesh
YR 2024
UL http://medrxiv.org/content/early/2024/06/30/2023.09.24.23296031.abstract
AB Purpose To calculate the annual enhanced coverage costs for covering the total and unmet need of cataract in India. To calculate the economic benefits of cataract burden averted. To calculate the net benefits of covering cataract needs.Setting We look at population-level data of India and its 30 states.Design This is a retrospective cross-sectional analysis for 2018-19.Methods We conducted a retrospective cross-sectional analysis for India and its 30 states. Data was taken from Global Burden of Disease 2019, the National Health Profile 2020, and the National Health Accounts 2021. We used ten per-capita surgical costs to calculate enhanced coverage costs. Enhanced coverage costs for the total need were calculated by multiplying prevalence with per-capita costs. For unmet need, the difference between the prevalence and surgeries achieved was used. For economic benefits of averted cataract burden, we multiplied disability-adjusted life-years (DALYs) with non-health GDP per capita, i.e., GDP - the government health expenditure. DALYs for unmet needs were calculated by multiplying DALYs with the ratio of unmet to total needs. For net benefits, we subtracted the enhanced coverage costs for meeting total and unmet needs from economic benefits.Results The annual enhanced coverage costs for covering total cataract needs in India were 0.92 - 4.9 billion USD. Costs for covering unmet needs were 0.72 - 3.82 billion USD. Nationally, the economic benefit of averting the total cataract disease burden was 12.4 (95%UI: 8.9 - 16.7) billion USD, while the for covering the unmet burden was 9.7 (95%UI: 6.93 - 13) billion USD. Annual net benefits of covering total needs were 7.53 - 11.5 billion USD. Net benefits of covering unmet needs were 5.9 - 9 billion USD.Conclusion Enhancing coverage for cataract is cost-beneficial.Competing Interest StatementSiddhesh Zadey represents the Association for Socially Applicable Research (ASAR) on the drafting committee of the Maharashtra State Mental Health Policy. He has previously received honoraria from Think Global Health, Harvard Public Health Magazine, and The Hindu. He is on the advisory board of ASAR and Nivarana. Other authors declare no competing interests.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at https://doi.org/10.7910/DVN/DTEZXS https://doi.org/10.7910/DVN/DTEZXS